Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase
- PMID: 1738152
- DOI: 10.1021/jm00081a023
Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase
Erratum in
- J Med Chem 1992 Dec 11;35(25):4768
Abstract
Conformational analyses and molecular-shape comparisons were carried out on an analogue series of indanone-benzylpiperidine inhibitors of acetylcholinesterase (AChE). It was possible to define an active conformation with respect to the flexible geometry of the benzylpiperidine moiety, as well as an active conformation of the indanone ring-piperidine ring substructure for analogues having a single spacer group between these rings. No active conformation could be postulated for analogues having two or three spacer units between the indanone and piperidine conformation could be postulated for analogues having two or three spacer units between the indanone and piperidine rings. Still, a receptor binding model can be constructed for all indanone and piperidine ring substructures. The postulated active conformation for 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride (1a), a potent AChE inhibitor, is close to the crystal structures of 1a with respect to the indanone-piperidine substructure, but differs from the crystal structures for the benzylpiperidine moiety. However, the crystal conformations and the postulated active conformation of the benzylpiperidine portion of the AChE inhibitor are estimated to be about equally stable. A trans-decalin analogue of 1a can adopt the postulated active conformation as shown by calculation and as seen in its crystal structure. The inactivity of this analogue is explained by the added steric size of the decalin unit and/or the time-average valence geometry behavior at the spiro junction to the indanone ring.
Similar articles
-
QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.J Med Chem. 1992 Feb 7;35(3):584-9. doi: 10.1021/jm00081a022. J Med Chem. 1992. PMID: 1738151
-
The rationale for E2020 as a potent acetylcholinesterase inhibitor.Bioorg Med Chem. 1996 Sep;4(9):1429-46. doi: 10.1016/0968-0896(96)00137-x. Bioorg Med Chem. 1996. PMID: 8894101
-
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds.J Med Chem. 1995 Nov 24;38(24):4821-9. doi: 10.1021/jm00024a009. J Med Chem. 1995. PMID: 7490731
-
[Advances in search for acetylcholinesterase inhibitor based on the double active sites hypothesis].Yao Xue Xue Bao. 2002 Sep;37(9):749-52. Yao Xue Xue Bao. 2002. PMID: 12567905 Review. Chinese. No abstract available.
-
Recent developments in biological activities of indanones.Eur J Med Chem. 2017 Sep 29;138:182-198. doi: 10.1016/j.ejmech.2017.06.032. Epub 2017 Jun 21. Eur J Med Chem. 2017. PMID: 28667874 Review.
Cited by
-
Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease.J Mol Neurosci. 2003;20(3):369-83. doi: 10.1385/JMN:20:3:369. J Mol Neurosci. 2003. PMID: 14501022 Review.
-
Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses.Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):25-9. doi: 10.1046/j.1365-2125.1998.0460s1025.x. Br J Clin Pharmacol. 1998. PMID: 9839762 Free PMC article. Clinical Trial.
-
Template-based de novo design for type II kinase inhibitors and its extented application to acetylcholinesterase inhibitors.Molecules. 2013 Oct 31;18(11):13487-509. doi: 10.3390/molecules181113487. Molecules. 2013. PMID: 24184819 Free PMC article.
-
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses.Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):7-12. doi: 10.1046/j.1365-2125.1998.0460s1007.x. Br J Clin Pharmacol. 1998. PMID: 9839759 Free PMC article. Clinical Trial.
-
Synthesis of bistetrahydroquinolines as potential anticholinesterasic agents by double Diels-Alder reactions.Molecules. 2013 Oct 17;18(10):12951-65. doi: 10.3390/molecules181012951. Molecules. 2013. PMID: 24141245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information